4//SEC Filing
Sylvain Jereme M 4
Accession 0001093557-24-000013
CIK 0001093557other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 6:54 PM ET
Size
7.0 KB
Accession
0001093557-24-000013
Insider Transaction Report
Form 4
DEXCOM INCDXCM
Sylvain Jereme M
EVP, Chief Financal Officer
Transactions
- Sale
Common Stock
2024-01-16$123.63/sh−2,734$338,018→ 74,505 total - Award
Common Stock
2024-01-12$0.00/sh+7,171$7→ 77,239 total
Footnotes (3)
- [F1]Represents performance stock units ("PSUs") granted to the reporting person on March 8, 2021 that vested on January 12, 2024.
- [F2]Included in this number are 48,809 unvested restricted stock units, 21,769 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 14,124 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 5,848 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 7,068 of which were granted on March 8, 2021 and shall vest through March 8, 2024.
- [F3]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of PSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Documents
Issuer
DEXCOM INC
CIK 0001093557
Entity typeother
Related Parties
1- filerCIK 0001681267
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 6:54 PM ET
- Size
- 7.0 KB